Loss of L-FABP and HNF-1α inactivation is a consistent feature of fibrolamellar carcinoma while HNF-1α mutation is an important occurrence in fibrolamellar carcinoma pathogenesis [13]. The gene discussed is HNF1A; the disease is fibrolamellar hepatocellular carcinoma.